← 產業報告目錄

Osteosynthesis Implants Market Research Report Information By Product (Screws and Plates, Wires and Pins, Intramedullary Rods and Nails, and Spinal Fixation Devices), By Material (Stainless Steel, Titanium and Titanium Alloys, Bioabsorbable Polymers, and Others), By Fracture Type (Hip Fracture, Knee Fracture, Spine Fracture, Shoulder Fracture, and Others), By End User (Hospitals, Orthopaedic Clinics, and Ambulatory Surgical Centers) and by Region (North America, Europe, Asia-Pacific, and Rest of the World) Forecast till 2032

出版商 Market Research Future產業別 Healthcare & Life Sciences出版日期 2025-05-02頁數 149報告編號 MRFRHC20010CR

授權報價

Single User Price$4,950 USD
Multi User Licence (up to 10 users)$5,950 USD
Enterprisewide Price (Global Site License)$7,250 USD
洽詢購買 申請 Sample

報告摘要

Osteosynthesis Implants Market Research Report Information By Product (Screws and Plates, Wires and Pins, Intramedullary Rods and Nails, and Spinal Fixation Devices), By Material (Stainless Steel, Titanium and Titanium Alloys, Bioabsorbable Polymers, and Others), By Fracture Type (Hip Fracture, Knee Fracture, Spine Fracture, Shoulder Fracture, and Others), By End User (Hospitals, Orthopaedic Clinics, and Ambulatory Surgical Centers) and by Region (North America, Europe, Asia-Pacific, and Rest of the World) Forecast till 2032 Market Overview The Osteosynthesis Implants Market is anticipated to experience a compound annual growth rate (CAGR) of 6.99% from USD 5.67 Billion in 2024 to USD 9.66 Billion by 2032. The global osteosynthesis implant market is being driven by the increasing prevalence of fractures and the rising incidence of osteoporosis worldwide. Nevertheless, the global market is anticipated to be constrained by the complications associated with osteosynthesis implants. However, the market is expected to generate profitable opportunities because of the global elderly population, ongoing clinical trials, and the acceleration of technological advancements. The management of fractures is significantly complicated by osteoporosis, which is defined by a reduction in bone density and an increase in fragility. Osteoporosis increases the likelihood of fractures, particularly in weight-bearing bones like the hip, spine, and wrist. Fractures in osteoporotic bones frequently pose distinctive obstacles as a result of compromised bone quality and diminished mechanical stability. Osteosynthesis implants are essential in the treatment of fractures in osteoporotic patients, as they facilitate fracture healing and provide mechanical support. Market segment insights The segmentation of global osteosynthesis implants by product, screws and plates, wires and pins, intramedullary rods and nails, and spinal fixation devices. Stainless steel, titanium and titanium alloys, bioabsorbable polymers, and other materials comprise the market segmentation. The market has been segmented according to the type of fracture, including hip fracture, knee fracture, spine fracture, shoulder fracture, and others. Hospitals, orthopedic clinics, and ambulatory surgical centers comprise the Osteosynthesis Implants Market, which has been segmented by end user. Regional Perspectives In 2022, North America Osteosynthesis Implants held the largest market share at 39.76%. It is expected to grow at a compound annual growth rate (CAGR) of 6.33% over the forecast period to reach approximately USD 3.98 billion by 2032. Nevertheless, Europe is anticipated to experience the most significant compound annual growth rate (CAGR) of 7.35% during the forecast period. The North American Osteosynthesis Implants market is expected to experience sustained growth, which is a promising development. The osteosynthesis implants market is characterized by a high incidence of trauma and sports injuries, a rise in the number of orthopedic interventions, and an exceptional healthcare infrastructure and facilities. The European Osteosynthesis Implants market is currently experiencing significant growth, which is being driven by a combination of factors. These factors include the increasing prevalence of osteoporosis, the growing number of sports injuries, and the growing awareness of the benefits of surgical intervention among patients. In 2022, the Asia-Pacific Osteosynthesis Implants market was valued at USD 0.99 billion and is anticipated to expand at a compound annual growth rate (CAGR) of 5.13% over the forecast period. Furthermore, the market's expansion is further bolstered by the rapid population growth and the expanding healthcare infrastructure in developing countries. In 2022, the Rest of the World Osteosynthesis Implants market was valued at USD 0.71 billion and is anticipated to expand at a compound annual growth rate (CAGR) of 2.76% over the projection period. The Middle East, Africa, and Latin America comprise the remainder of the world. Major Players Medartis AG, Dieter Marquardt Medizintechnik GmbH, Lepu Medical Technology (Beijing)Co.,Ltd., Globus Medical, Inc., Zimmer Biomet, Arthrex, Inc., Precision Spine, Inc., Johnson & Johnson Services, Inc., CONMED Corporation., and Braun SE are among the key companies in the osteosynthesis implant market.
目錄 Table of Contents
TABLE OF CONTENTS 1 EXECUTIVE SUMMARY ............................................................................................................... 17 2 MARKET INTRODUCTION ............................................................................................................ 19 2.1 DEFINITION .................................................................................................................................................................. 19 2.2 SCOPE OF THE STUDY .............................................................................................................................................. 19 2.3 RESEARCH OBJECTIVE ............................................................................................................................................ 19 2.4 MARKET STRUCTURE .............................................................................................................................................. 19 3 RESEARCH METHODOLOGY ...................................................................................................... 20 3.1 OVERVIEW .................................................................................................................................................................... 20 3.2 DATA FLOW .................................................................................................................................................................. 22 3.2.1 DATA MINING PROCESS ................................................................................................................................. 22 3.3 PURCHASED DATABASE: ......................................................................................................................................... 23 3.4 SECONDARY SOURCES: ............................................................................................................................................ 24 3.4.1 SECONDARY RESEARCH DATA FLOW: ............................................................................................................. 25 3.5 PRIMARY RESEARCH: ............................................................................................................................................... 26 3.5.1 PRIMARY RESEARCH DATA FLOW: ................................................................................................................. 27 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED ......................................................................... 28 3.6 APPROACHES FOR MARKET SIZE ESTIMATION: ........................................................................................... 29 3.6.1 REVENUE ANALYSIS APPROACH ..................................................................................................................... 29 3.7 DATA FORECASTING................................................................................................................................................. 30 3.7.1 DATA FORECASTING TECHNIQUE .................................................................................................................... 30 3.8 DATA MODELLING ..................................................................................................................................................... 31 3.8.1 MICROECONOMIC FACTOR ANALYSIS: ............................................................................................................ 31 3.8.2 DATA MODELLING: ......................................................................................................................................... 32 3.9 TEAMS AND ANALYST CONTRIBUTION ........................................................................................................... 34 4 MARKET DYNAMICS .................................................................................................................... 36 4.1 INTRODUCTION ........................................................................................................................................................... 36 4.2 DRIVERS ......................................................................................................................................................................... 37 4.2.1 RISING INCIDENCES OF OSTEOPOROSIS ACROSS THE GLOBE .......................................................................... 37 4.2.2 INCREASING INCIDENCE OF FRACTURES ......................................................................................................... 38 4.3 RESTRAINTS ................................................................................................................................................................ 39 4.3.1 COMPLICATIONS ASSOCIATED WITH OSTEOSYNTHESIS IMPLANTS ................................................................ 39 4.4 OPPORTUNITY ............................................................................................................................................................. 40 4.4.1 GROWING TECHNOLOGICAL ADVANCMENTS AND ONGOING CLINICAL TRIALS ................................................ 40 4.4.2 INCREASING ELDERLY POPULATION, WORLDWIDE ........................................................................................... 40 5 MARKET FACTOR ANALYSIS ...................................................................................................... 41 5.1 PORTER'S FIVE FORCES MODEL ........................................................................................................................... 41 5.1.1 THREAT OF NEW ENTRANTS ........................................................................................................................... 41 5.1.2 BARGAINING POWER OF SUPPLIERS ............................................................................................................... 42 5.1.3 THREAT OF SUBSTITUTES .............................................................................................................................. 42 5.1.4 BARGAINING POWER OF BUYERS .................................................................................................................... 42 5.1.5 INTENSITY OF RIVALRY .................................................................................................................................. 42 5.2 IMPACT OF COVID-19 ON THE GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET ............................. 43 6 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, BY PRODUCT ............................................ 45 6.1 OVERVIEW .................................................................................................................................................................... 45 6.2 SCREWS AND PLATES .............................................................................................................................................. 47 6.3 WIRES AND PINS ........................................................................................................................................................ 48 6.4 INTRAMEDULLARY RODS AND NAILS ............................................................................................................... 48 6.5 SPINAL FIXATION DEVICES ................................................................................................................................... 49 7 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, BY MATERIAL ........................................... 50 7.1 OVERVIEW .................................................................................................................................................................... 50 7.2 STAINLESS STEEL ..................................................................................................................................................... 52 7.3 TITANIUM AND TITANIUM ALLOYS .................................................................................................................. 53 7.4 BIOABSORBABLE POLYMERS................................................................................................................................. 53 7.5 OTHERS .......................................................................................................................................................................... 54 8 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, BY FRACTURE TYPE ................................ 55 8.1 OVERVIEW .................................................................................................................................................................... 55 8.2 HIP FRACTURE ............................................................................................................................................................ 57 8.3 KNEE FRACTURE ....................................................................................................................................................... 58 8.4 SPINE FRACTURE ....................................................................................................................................................... 58 8.5 SHOULDER FRACTURE ............................................................................................................................................. 59 8.6 OTHERS .......................................................................................................................................................................... 59 9 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, BY END USER ........................................... 60 9.1 OVERVIEW .................................................................................................................................................................... 60 9.2 HOSPITALS ................................................................................................................................................................... 61 9.3 ORTHOPAEDIC CLINICS ............................................................................................................................................ 62 9.4 AMBULATORY SURGICAL CENTERS ................................................................................................................... 62 10 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, BY REGION ............................................... 63 10.1 OVERVIEW .................................................................................................................................................................... 63 10.2 NORTH AMERICA ....................................................................................................................................................... 65 10.2.1 US.................................................................................................................................................................. 68 10.2.2 CANADA ........................................................................................................................................................ 70 10.3 EUROPE .......................................................................................................................................................................... 72 10.3.1 GERMANY ...................................................................................................................................................... 75 10.3.2 FRANCE ......................................................................................................................................................... 76 10.3.3 UK ................................................................................................................................................................. 78 10.3.4 ITALY ............................................................................................................................................................. 79 10.3.5 SPAIN ............................................................................................................................................................ 80 10.3.6 REST OF EUROPE ............................................................................................................................................ 82 10.4 ASIA-PACIFIC ............................................................................................................................................................... 84 10.4.1 CHINA ............................................................................................................................................................ 87 10.4.2 INDIA ............................................................................................................................................................. 88 10.4.3 JAPAN ........................................................................................................................................................... 90 10.4.4 SOUTH KOREA ................................................................................................................................................ 91 10.4.5 AUSTRALIA .................................................................................................................................................... 92 10.4.6 REST OF ASIA-PACIFIC ................................................................................................................................... 94 10.5 REST OF THE WORLD ................................................................................................................................................ 96 10.5.1 MIDDLE EAST & AFRICA .................................................................................................................................. 99 10.5.2 LATIN AMERICA ............................................................................................................................................. 100 11 COMPETITIVE LANDSCAPE ........................................................................................................ 103 11.1 INTRODUCTION ........................................................................................................................................................... 103 11.2 MARKET SHARE ANALYSIS, 2022 ....................................................................................................................... 103 11.3 COMPETITOR DASHBOARD..................................................................................................................................... 104 11.4 PUBLIC PLAYERS STOCK SUMMARY ................................................................................................................. 105 11.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL .............................................................................. 105 11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES ............................................................................................ 106 11.6.1 PRODUCT LAUNCH/ PRODUCT APPROVAL ...................................................................................................... 106 11.6.2 MERGER ......................................................................................................................................................... 107 11.6.3 ACQUISITION ................................................................................................................................................. 107 12 COMPANY PROFILES .................................................................................................................. 108 12.1 B. BRAUN SE ................................................................................................................................................................. 108 12.1.1 COMPANY OVERVIEW ..................................................................................................................................... 108 12.1.2 FINANCIAL OVERVIEW .................................................................................................................................... 109 12.1.3 PRODUCTS OFFERED ...................................................................................................................................... 109 12.1.4 KEY DEVELOPMENTS ...................................................................................................................................... 110 12.1.5 SWOT ANALYSIS ............................................................................................................................................ 111 12.1.6 KEY STRATEGIES ............................................................................................................................................ 111 12.2 JOHNSON & JOHNSON SERVICES, INC. ............................................................................................................... 112 12.2.1 COMPANY OVERVIEW ..................................................................................................................................... 112 12.2.2 FINANCIAL OVERVIEW .................................................................................................................................... 113 12.2.3 PRODUCTS OFFERED ...................................................................................................................................... 113 12.2.4 KEY DEVELOPMENTS ...................................................................................................................................... 115 12.2.5 SWOT ANALYSIS ............................................................................................................................................ 115 12.2.6 KEY STRATEGIES ............................................................................................................................................ 116 12.3 CONMED CORPORATION .......................................................................................................................................... 117 12.3.1 COMPANY OVERVIEW ..................................................................................................................................... 117 12.3.2 FINANCIAL OVERVIEW .................................................................................................................................... 118 12.3.3 PRODUCTS OFFERED ...................................................................................................................................... 118 12.3.4 KEY DEVELOPMENTS ...................................................................................................................................... 119 12.3.5 KEY STRATEGIES ............................................................................................................................................ 120 12.4 GLOBUS MEDICAL, INC. ............................................................................................................................................ 121 12.4.1 COMPANY OVERVIEW ..................................................................................................................................... 121 12.4.2 FINANCIAL OVERVIEW .................................................................................................................................... 122 12.4.3 PRODUCTS OFFERED ...................................................................................................................................... 122 12.4.4 KEY DEVELOPMENTS ...................................................................................................................................... 124 12.4.5 SWOT ANALYSIS ............................................................................................................................................ 125 12.4.6 KEY STRATEGIES ............................................................................................................................................ 125 12.5 ZIMMER BIOMET ........................................................................................................................................................ 126 12.5.1 COMPANY OVERVIEW ..................................................................................................................................... 126 12.5.2 FINANCIAL OVERVIEW .................................................................................................................................... 127 12.5.3 PRODUCTS OFFERED ...................................................................................................................................... 127 12.5.4 KEY DEVELOPMENTS ...................................................................................................................................... 128 12.5.5 SWOT ANALYSIS ............................................................................................................................................ 129 12.5.6 KEY STRATEGIES ............................................................................................................................................ 129 12.6 ARTHREX, INC. ............................................................................................................................................................ 130 12.6.1 COMPANY OVERVIEW ..................................................................................................................................... 130 12.6.2 FINANCIAL OVERVIEW .................................................................................................................................... 130 12.6.3 PRODUCTS OFFERED ...................................................................................................................................... 130 12.6.4 KEY DEVELOPMENTS ...................................................................................................................................... 131 12.6.5 KEY STRATEGIES ............................................................................................................................................ 131 12.7 PRECISION SPINE INC. .............................................................................................................................................. 132 12.7.1 COMPANY OVERVIEW ..................................................................................................................................... 132 12.7.2 FINANCIAL OVERVIEW .................................................................................................................................... 132 12.7.3 PRODUCTS OFFERED ...................................................................................................................................... 132 12.7.4 KEY DEVELOPMENTS ...................................................................................................................................... 133 12.7.5 KEY STRATEGIES ............................................................................................................................................ 133 12.8 MEDARTIS AG .............................................................................................................................................................. 134 12.8.1 COMPANY OVERVIEW ..................................................................................................................................... 134 12.8.2 FINANCIAL OVERVIEW .................................................................................................................................... 135 12.8.3 PRODUCTS OFFERED ...................................................................................................................................... 135 12.8.4 KEY DEVELOPMENTS ...................................................................................................................................... 138 12.8.5 KEY STRATEGIES ............................................................................................................................................ 138 12.9 DIETER MARQUARDT MEDIZINTECHNIK GMBH ........................................................................................... 139 12.9.1 COMPANY OVERVIEW ..................................................................................................................................... 139 12.9.2 FINANCIAL OVERVIEW .................................................................................................................................... 139 12.9.3 PRODUCTS OFFERED ...................................................................................................................................... 139 12.9.4 KEY DEVELOPMENTS ...................................................................................................................................... 141 12.9.5 KEY STRATEGIES ............................................................................................................................................ 141 12.10 LEPU MEDICAL TECHNOLOGY(BEIJING)CO., LTD. .......................................................................................... 142 12.10.1 COMPANY OVERVIEW ..................................................................................................................................... 142 12.10.2 FINANCIAL OVERVIEW .................................................................................................................................... 143 12.10.3 PRODUCTS OFFERED ...................................................................................................................................... 143 12.10.4 KEY DEVELOPMENTS ...................................................................................................................................... 146 12.10.5 SWOT ANALYSIS ............................................................................................................................................ 146 12.10.6 KEY STRATEGIES ............................................................................................................................................ 146 13 DATA CITATIONS ......................................................................................................................... 148
圖表清單 List of Tables & Figures
LIST OF TABLES TABLE 1 QFD MODELLING FOR MARKET SHARE ASSESSMENT 32 TABLE 2 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 46 TABLE 3 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, FOR SCREWS AND PLATES, BY REGION, 2019–2032 (USD MILLION) 47 TABLE 4 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, FOR WIRES AND PINS, BY REGION, 2019–2032 (USD MILLION) 48 TABLE 5 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, FOR INTRAMEDULLARY RODS AND NAILS, BY REGION, 2019–2032 (USD MILLION) 48 TABLE 6 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, FOR SPINAL FIXATION DEVICES, BY REGION, 2019–2032 (USD MILLION) 49 TABLE 7 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, BY MATERIAL, 2019–2032 (USD MILLION) 51 TABLE 8 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, FOR STAINLESS STEEL, BY REGION, 2019–2032 (USD MILLION) 52 TABLE 9 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, FOR TITANIUM AND TITANIUM ALLOYS, BY REGION, 2019–2032 (USD MILLION) 53 TABLE 10 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, FOR BIOABSORBABLE POLYMERS, BY REGION, 2019–2032 (USD MILLION) 53 TABLE 11 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION) 54 TABLE 12 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, BY FRACTURE TYPE, 2019–2032 (USD MILLION) 56 TABLE 13 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, FOR HIP FRACTURE, BY REGION, 2019–2032 (USD MILLION) 57 TABLE 14 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, FOR KNEE FRACTURE, BY REGION, 2019–2032 (USD MILLION) 58 TABLE 15 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, FOR SPINE FRACTURE, BY REGION, 2019–2032 (USD MILLION) 58 TABLE 16 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, FOR SHOULDER FRACTURE, BY REGION, 2019–2032 (USD MILLION) 59 TABLE 17 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION) 59 TABLE 18 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, BY END USER, 2019–2032 (USD MILLION) 61 TABLE 19 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, FOR HOSPITAL, BY REGION, 2019–2032 (USD MILLION) 61 TABLE 20 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, FOR ORTHOPAEDIC CLINICS, BY REGION, 2019–2032 (USD MILLION) 62 TABLE 21 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2019–2032 (USD MILLION) 62 TABLE 22 GLOBAL: OSTEOSYNTHESIS IMPLANTS MARKET, BY REGION, 2019–2032 (USD MILLION) 64 TABLE 23 NORTH AMERICA: OSTEOSYNTHESIS IMPLANTS MARKET, BY COUNTRY, 2019–2032 (USD MILLION) 67 TABLE 24 NORTH AMERICA: OSTEOSYNTHESIS IMPLANTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 67 TABLE 25 NORTH AMERICA: OSTEOSYNTHESIS IMPLANTS MARKET, BY MATERIAL, 2019-2032 (USD MILLION) 67 TABLE 26 NORTH AMERICA: OSTEOSYNTHESIS IMPLANTS MARKET, BY FRACTURE TYPE, 2019-2032 (USD MILLION) 68 TABLE 27 NORTH AMERICA: OSTEOSYNTHESIS IMPLANTS MARKET, BY END USER, 2019–2032 (USD MILLION) 68 TABLE 28 US: OSTEOSYNTHESIS IMPLANTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 68 TABLE 29 US: OSTEOSYNTHESIS IMPLANTS MARKET, BY MATERIAL, 2019-2032 (USD MILLION) 69 TABLE 30 US: OSTEOSYNTHESIS IMPLANTS MARKET, BY FRACTURE TYPE, 2019-2032 (USD MILLION) 69 TABLE 31 US: OSTEOSYNTHESIS IMPLANTS MARKET, BY END USER, 2019–2032 (USD MILLION) 69 TABLE 32 CANADA: OSTEOSYNTHESIS IMPLANTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 70 TABLE 33 CANADA: OSTEOSYNTHESIS IMPLANTS MARKET, BY MATERIAL, 2019-2032 (USD MILLION) 70 TABLE 34 CANADA: OSTEOSYNTHESIS IMPLANTS MARKET, BY FRACTURE TYPE, 2019-2032 (USD MILLION) 70 TABLE 35 CANADA: OSTEOSYNTHESIS IMPLANTS MARKET, BY END USER, 2019–2032 (USD MILLION) 71 TABLE 36 EUROPE: OSTEOSYNTHESIS IMPLANTS MARKET, BY COUNTRY, 2019–2032 (USD MILLION) 73 TABLE 37 EUROPE: OSTEOSYNTHESIS IMPLANTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 73 TABLE 38 EUROPE: OSTEOSYNTHESIS IMPLANTS MARKET, BY MATERIAL, 2019-2032 (USD MILLION) 74 TABLE 39 EUROPE: OSTEOSYNTHESIS IMPLANTS MARKET, BY FRACTURE TYPE, 2019-2032 (USD MILLION) 74 TABLE 40 EUROPE: OSTEOSYNTHESIS IMPLANTS MARKET, BY END USER, 2019–2032 (USD MILLION) 75 TABLE 41 GERMANY: OSTEOSYNTHESIS IMPLANTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 75 TABLE 42 GERMANY: OSTEOSYNTHESIS IMPLANTS MARKET, BY MATERIAL, 2019-2032 (USD MILLION) 75 TABLE 43 GERMANY: OSTEOSYNTHESIS IMPLANTS MARKET, BY FRACTURE TYPE, 2019-2032 (USD MILLION) 76 TABLE 44 GERMANY: OSTEOSYNTHESIS IMPLANTS MARKET, BY END USER, 2019–2032 (USD MILLION) 76 TABLE 45 FRANCE: OSTEOSYNTHESIS IMPLANTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 76 TABLE 46 FRANCE: OSTEOSYNTHESIS IMPLANTS MARKET, BY MATERIAL, 2019-2032 (USD MILLION) 77 TABLE 47 FRANCE: OSTEOSYNTHESIS IMPLANTS MARKET, BY FRACTURE TYPE, 2019-2032 (USD MILLION) 77 TABLE 48 FRANCE: OSTEOSYNTHESIS IMPLANTS MARKET, BY END USER, 2019–2032 (USD MILLION) 77 TABLE 49 UK: OSTEOSYNTHESIS IMPLANTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 78 TABLE 50 UK: OSTEOSYNTHESIS IMPLANTS MARKET, BY MATERIAL, 2019-2032 (USD MILLION) 78 TABLE 51 UK: OSTEOSYNTHESIS IMPLANTS MARKET, BY FRACTURE TYPE, 2019-2032 (USD MILLION) 78 TABLE 52 UK: OSTEOSYNTHESIS IMPLANTS MARKET, BY END USER, 2019–2032 (USD MILLION) 79 TABLE 53 ITALY: OSTEOSYNTHESIS IMPLANTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 79 TABLE 54 ITALY: OSTEOSYNTHESIS IMPLANTS MARKET, BY MATERIAL, 2019-2032 (USD MILLION) 79 TABLE 55 ITALY: OSTEOSYNTHESIS IMPLANTS MARKET, BY FRACTURE TYPE, 2019-2032 (USD MILLION) 80 TABLE 56 ITALY: OSTEOSYNTHESIS IMPLANTS MARKET, BY END USER, 2019–2032 (USD MILLION) 80 TABLE 57 SPAIN: OSTEOSYNTHESIS IMPLANTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 80 TABLE 58 SPAIN: OSTEOSYNTHESIS IMPLANTS MARKET, BY MATERIAL, 2019-2032 (USD MILLION) 81 TABLE 59 SPAIN: OSTEOSYNTHESIS IMPLANTS MARKET, BY FRACTURE TYPE, 2019-2032 (USD MILLION) 81 TABLE 60 SPAIN: OSTEOSYNTHESIS IMPLANTS MARKET, BY END USER, 2019–2032 (USD MILLION) 81 TABLE 61 REST OF EUROPE: OSTEOSYNTHESIS IMPLANTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 82 TABLE 62 REST OF EUROPE: OSTEOSYNTHESIS IMPLANTS MARKET, BY MATERIAL, 2019-2032 (USD MILLION) 82 TABLE 63 REST OF EUROPE: OSTEOSYNTHESIS IMPLANTS MARKET, BY FRACTURE TYPE, 2019-2032 (USD MILLION) 82 TABLE 64 REST OF EUROPE: OSTEOSYNTHESIS IMPLANTS MARKET, BY END USER, 2019–2032 (USD MILLION) 83 TABLE 65 ASIA-PACIFIC: OSTEOSYNTHESIS IMPLANTS MARKET, BY COUNTRY, 2019–2032 (USD MILLION) 85 TABLE 66 ASIA-PACIFIC: OSTEOSYNTHESIS IMPLANTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 86 TABLE 67 ASIA-PACIFIC: OSTEOSYNTHESIS IMPLANTS MARKET, BY MATERIAL, 2019–2032 (USD MILLION) 86 TABLE 68 ASIA-PACIFIC: OSTEOSYNTHESIS IMPLANTS MARKET, BY FRACTURE TYPE, 2019–2032 (USD MILLION) 86 TABLE 69 ASIA-PACIFIC: OSTEOSYNTHESIS IMPLANTS MARKET, BY END USER, 2019–2032 (USD MILLION) 87 TABLE 70 CHINA: OSTEOSYNTHESIS IMPLANTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 87 TABLE 71 CHINA: OSTEOSYNTHESIS IMPLANTS MARKET, BY MATERIAL, 2019–2032 (USD MILLION) 87 TABLE 72 CHINA: OSTEOSYNTHESIS IMPLANTS MARKET, BY FRACTURE TYPE, 2019–2032 (USD MILLION) 88 TABLE 73 CHINA: OSTEOSYNTHESIS IMPLANTS MARKET, BY END USER, 2019–2032 (USD MILLION) 88 TABLE 74 INDIA: OSTEOSYNTHESIS IMPLANTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 88 TABLE 75 INDIA: OSTEOSYNTHESIS IMPLANTS MARKET, BY MATERIAL, 2019–2032 (USD MILLION) 89 TABLE 76 INDIA: OSTEOSYNTHESIS IMPLANTS MARKET, BY FRACTURE TYPE, 2019–2032 (USD MILLION) 89 TABLE 77 INDIA: OSTEOSYNTHESIS IMPLANTS MARKET, BY END USER, 2019–2032 (USD MILLION) 89 TABLE 78 JAPAN: OSTEOSYNTHESIS IMPLANTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 90 TABLE 79 JAPAN: OSTEOSYNTHESIS IMPLANTS MARKET, BY MATERIAL, 2019–2032 (USD MILLION) 90 TABLE 80 JAPAN: OSTEOSYNTHESIS IMPLANTS MARKET, BY FRACTURE TYPE, 2019–2032 (USD MILLION) 90 TABLE 81 JAPAN: OSTEOSYNTHESIS IMPLANTS MARKET, BY END USER, 2019–2032 (USD MILLION) 91 TABLE 82 SOUTH KOREA: OSTEOSYNTHESIS IMPLANTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 91 TABLE 83 SOUTH KOREA: OSTEOSYNTHESIS IMPLANTS MARKET, BY MATERIAL, 2019–2032 (USD MILLION) 91 TABLE 84 SOUTH KOREA: OSTEOSYNTHESIS IMPLANTS MARKET, BY FRACTURE TYPE, 2019–2032 (USD MILLION) 92 TABLE 85 SOUTH KOREA: OSTEOSYNTHESIS IMPLANTS MARKET, BY END USER, 2019–2032 (USD MILLION) 92 TABLE 86 AUSTRALIA: OSTEOSYNTHESIS IMPLANTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 92 TABLE 87 AUSTRALIA: OSTEOSYNTHESIS IMPLANTS MARKET, BY MATERIAL, 2019–2032 (USD MILLION) 93 TABLE 88 AUSTRALIA: OSTEOSYNTHESIS IMPLANTS MARKET, BY FRACTURE TYPE, 2019–2032 (USD MILLION) 93 TABLE 89 AUSTRALIA: OSTEOSYNTHESIS IMPLANTS MARKET, BY END USER, 2019–2032 (USD MILLION) 93 TABLE 90 REST OF ASIA-PACIFIC: OSTEOSYNTHESIS IMPLANTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 94 TABLE 91 REST OF ASIA-PACIFIC: OSTEOSYNTHESIS IMPLANTS MARKET, BY MATERIAL, 2019–2032 (USD MILLION) 94 TABLE 92 REST OF ASIA-PACIFIC: OSTEOSYNTHESIS IMPLANTS MARKET, BY FRACTURE TYPE, 2019–2032 (USD MILLION) 94 TABLE 93 REST OF ASIA-PACIFIC: OSTEOSYNTHESIS IMPLANTS MARKET, BY END USER, 2019–2032 (USD MILLION) 95 TABLE 94 REST OF THE WORLD: OSTEOSYNTHESIS IMPLANTS MARKET, BY REGION, 2019–2032 (USD MILLION) 97 TABLE 95 REST OF THE WORLD: OSTEOSYNTHESIS IMPLANTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 97 TABLE 96 REST OF THE WORLD: OSTEOSYNTHESIS IMPLANTS MARKET, BY MATERIAL, 2019–2032 (USD MILLION) 98 TABLE 97 REST OF THE WORLD: OSTEOSYNTHESIS IMPLANTS MARKET, BY FRACTURE TYPE, 2019–2032 (USD MILLION) 98 TABLE 98 REST OF THE WORLD: OSTEOSYNTHESIS IMPLANTS MARKET, BY END USER, 2019–2032 (USD MILLION) 98 TABLE 99 MIDDLE EAST & AFRICA: OSTEOSYNTHESIS IMPLANTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 99 TABLE 100 MIDDLE EAST & AFRICA: OSTEOSYNTHESIS IMPLANTS MARKET, BY MATERIAL, 2019–2032 (USD MILLION) 99 TABLE 101 MIDDLE EAST & AFRICA: OSTEOSYNTHESIS IMPLANTS MARKET, BY FRACTURE TYPE, 2019–2032 (USD MILLION) 99 TABLE 102 MIDDLE EAST & AFRICA: OSTEOSYNTHESIS IMPLANTS MARKET, BY END USER, 2019–2032 (USD MILLION) 100 TABLE 103 LATIN AMERICA: OSTEOSYNTHESIS IMPLANTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 100 TABLE 104 LATIN AMERICA: OSTEOSYNTHESIS IMPLANTS MARKET, BY MATERIAL, 2019–2032 (USD MILLION) 100 TABLE 105 LATIN AMERICA: OSTEOSYNTHESIS IMPLANTS MARKET, BY FRACTURE TYPE, 2019–2032 (USD MILLION) 101 TABLE 106 LATIN AMERICA: OSTEOSYNTHESIS IMPLANTS MARKET, BY END USER, 2019–2032 (USD MILLION) 101 TABLE 107 PUBLIC PLAYERS STOCK SUMMARY 105 TABLE 108 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL 105 TABLE 109 PRODUCT LAUNCH/ PRODUCT APPROVAL 106 TABLE 110 MERGER 107 TABLE 111 ACQUISITION 107 TABLE 112 B. BRAUN SE: PRODUCTS OFFERED 109 TABLE 113 JOHNSON & JOHNSON SERVICES, INC.: PRODCUTS OFFERED 113 TABLE 114 JOHNSON & JOHNSON SERVICES, INC: KEY DEVELOPMENTS 115 TABLE 115 CONMED CORPORATION: PRODUCTS OFFERED 118 TABLE 116 GLOBUS MEDICAL, INC.: PRODUCTS OFFERED 122 TABLE 117 GLOBUS MEDICAL, INC.: KEY DEVELOPMENTS 124 TABLE 118 ZIMMER BIOMET: PRODUCTS OFFERED 127 TABLE 119 ARTHREX, INC.: PRODCUTS OFFERED 130 TABLE 120 ARTHREX, INC.: KEY DEVELOPMENTS 131 TABLE 121 PRECISION SPINE INC.: PRODCUTS OFFERED 132 TABLE 122 PRECISION SPINE INC.: KEY DEVELOPMENTS 133 TABLE 123 MEDARTIS AG: PRODUCT OFFERED 135 TABLE 124 MEDARTIS AG: KEY DEVELOPMENTS 138 TABLE 125 DIETER MARQUARDT MEDIZINTECHNIK GMBH: PRODUCT OFFERED 139 TABLE 126 LEPU MEDICAL TECHNOLOGY(BEIJING)CO., LTD. INC: PRODUCT OFFERED 143 LIST OF FIGURES FIGURE 1 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET: STRUCTURE 19 FIGURE 2 GLOBAL OSTEOSYNTHESIS IMPLANT MARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032) 36 FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032) 38 FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032) 39 FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET 41 FIGURE 6 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, PRODUCT SEGMENT ATTRACTIVENESS, 2019-2032 (USD MILLION) 45 FIGURE 7 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, BY PRODUCT, 2022 & 2032 (USD MILLION) 46 FIGURE 8 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET SHARE (%), BY PRODUCT, 2022 47 FIGURE 9 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, MATERIAL SEGMENT ATTRACTIVENESS, 2019-2032 (USD MILLION) 50 FIGURE 10 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, BY MATERIAL, 2022 & 2032 (USD MILLION) 51 FIGURE 11 GLOBAL OSTEOSYNTHESIS IMPLANTSMARKET SHARE (%), BY MATERIAL, 2022 52 FIGURE 12 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, FRACTURE TYPE SEGMENT ATTRACTIVENESS, 2019-2032 (USD MILLION) 55 FIGURE 13 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, BY FRACTURE TYPE, 2022 & 2032 (USD MILLION) 56 FIGURE 14 GLOBAL OSTEOSYNTHESIS IMPLANTSMARKET SHARE (%), BY FRACTURE TYPE, 2022 57 FIGURE 15 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, END USER SEGMENT ATTRACTIVENESS, 2019-2032 (USD MILLION) 60 FIGURE 16 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, BY END USER, 2022 & 2032 (USD MILLION) 60 FIGURE 17 GLOBAL OSTEOSYNTHESIS IMPLANTSMARKET SHARE (%), BY END USER, 2022 61 FIGURE 18 GLOBAL: OSTEOSYNTHESIS IMPLANTS MARKET, BY REGION, 2022 & 2032 (USD MILLION) 63 FIGURE 19 GLOBAL: OSTEOSYNTHESIS IMPLANTS MARKET SHARE (%), BY REGION, 2022 64 FIGURE 20 NORTH AMERICA OSTEOSYNTHESIS IMPLANTS MARKET, 2019-2032 (USD MILLION) 65 FIGURE 21 NORTH AMERICA: OSTEOSYNTHESIS IMPLANTS MARKET, BY COUNTRY, 2022 & 2032 (USD MILLION) 66 FIGURE 22 NORTH AMERICA: OSTEOSYNTHESIS IMPLANTS MARKET SHARE (%), BY COUNTRY, 2022 66 FIGURE 23 EUROPE OSTEOSYNTHESIS IMPLANTS MARKET, 2019-2032 (USD MILLION) 72 FIGURE 24 EUROPE: OSTEOSYNTHESIS IMPLANTS MARKET, BY COUNTRY, 2022 & 2032 (USD MILLION) 72 FIGURE 25 EUROPE: OSTEOSYNTHESIS IMPLANTS MARKET SHARE (%), BY COUNTRY, 2022 73 FIGURE 26 ASIA-PACIFIC MARKET ANALYSIS: OSTEOSYNTHESIS IMPLANTS MARKET, 2019-2032 (USD MILLION) 84 FIGURE 27 ASIA-PACIFIC: OSTEOSYNTHESIS IMPLANTS MARKET SHARE, BY COUNTRY, 2022 (% SHARE) 84 FIGURE 28 ASIA-PACIFIC: OSTEOSYNTHESIS IMPLANTS MARKET, BY COUNTRY, 2022 & 2032 (USD MILLION) 85 FIGURE 29 REST OF THE WORLD MARKET ANALYSIS: OSTEOSYNTHESIS IMPLANTS MARKET, 2019-2032 (USD MILLION) 96 FIGURE 30 REST OF THE WORLD: OSTEOSYNTHESIS IMPLANTS MARKET SHARE, BY REGION, 2022 (% SHARE) 96 FIGURE 31 REST OF THE WORLD: OSTEOSYNTHESIS IMPLANTS MARKET, BY REGION, 2022 & 2032 (USD MILLION) 97 FIGURE 32 OSTEOSYNTHESIS IMPLANTS MARKET PLAYERS: COMPETITIVE ANALSIS, 2022 103 FIGURE 33 COMPETITOR DASHBOARD: GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET 104 FIGURE 34 B. BRAUN SE: FINANCIAL OVERVIEW 109 FIGURE 35 B. BRAUN SE: SWOT ANALYSIS 111 FIGURE 36 JOHNSON & JOHNSON SERVICES, INC: FINANCIAL OVERVIEW SNAPSHOT 113 FIGURE 37 JOHNSON & JOHNSON SERVICES, INC: SWOT ANALYSIS 115 FIGURE 38 CONMED CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 118 FIGURE 39 GLOBUS MEDICAL, INC.: FINANCIAL OVERVIEW SNAPSHOT 122 FIGURE 40 GLOBUS MEDICAL, INC.: SWOT ANALYSIS 125 FIGURE 41 ZIMMER BIOMET: FINANCIAL OVERVIEW SNAPSHOT 127 FIGURE 42 ZIMMER BIOMET: SWOT ANALYSIS 129 FIGURE 43 MEDARTIS AG: FINANCIAL OVERVIEW SNAPSHOT 135 FIGURE 44 LEPU MEDICAL TECHNOLOGY(BEIJING)CO., LTD. INC: FINANCIAL OVERVIEW SNAPSHOT 143 FIGURE 45 LEPU MEDICAL TECHNOLOGY(BEIJING)CO., LTD. INC: SWOT ANALYSIS 146

提及公司

Medartis AGDieter Marquardt Medizintechnik GmbHLepu Medical Technology (Beijing)Co.Ltd.Globus MedicalIncZimmer BiometArthrexInc.Precision SpineIncJohnson & Johnson ServicesIncCONMED Corporation.and Braun SE

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們